The following is a summary of “Application of interpretable machine learning algorithm to predict lymph node metastasis in cutaneous malignant melanoma,” published in the April 2025 issue of ...

Doctors discuss the prevalence, risks and treatments of metastatic melanoma, as Teddi Mellencamp reveals the latest updates ...

Q: My sister-in-law is 82 years old and was recently diagnosed with melanoma. She has an appointment for treatment in a ...

Study findings show that the standardized 6-month surveillance protocols for all patients with low-risk uveal melanoma may be ...

A simple blood test could reveal who is at high risk of skin cancer recurrence after tumor-removal surgery. The test can ...

As temperatures soar and people make the most of the sunshine, it's important to make sure you keep your skin protected as ...

Patients with resected melanoma treated with a shorter duration of anti-PD1 therapy did not have worse outcomes than those treated for 12 months.

HealthDay News — For patients with unresectable metastatic uveal melanoma (mUM), the drug/device combination melphalan/hepatic delivery system (HDS) is efficacious and has a favorable risk-benefit ...

Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on ...

Researchers at Baylor College of Medicine, Texas Children's Hospital, the Hospital for Sick Children in Toronto and ...

The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant ...

Neoadjuvant pepinemab treatment shows potential to enhance immune response and improve survival in metastatic melanoma and head and neck cancer. Vaccinex, Inc. announced promising findings ...